A detailed history of Bill Few Associates, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bill Few Associates, Inc. holds 12,493 shares of MRK stock, worth $1.31 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
12,493
Previous 13,565 7.9%
Holding current value
$1.31 Million
Previous $1.68 Million 15.54%
% of portfolio
0.51%
Previous 0.65%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$111.15 - $128.97 $119,152 - $138,255
-1,072 Reduced 7.9%
12,493 $1.42 Million
Q2 2024

Jul 16, 2024

BUY
$123.8 - $132.96 $193,004 - $207,284
1,559 Added 12.99%
13,565 $1.68 Million
Q1 2024

Apr 18, 2024

BUY
$113.24 - $131.95 $79,834 - $93,024
705 Added 6.24%
12,006 $1.58 Million
Q4 2023

Jan 16, 2024

SELL
$100.18 - $109.02 $29,352 - $31,942
-293 Reduced 2.53%
11,301 $1.23 Million
Q3 2023

Oct 20, 2023

BUY
$102.95 - $114.33 $77,109 - $85,633
749 Added 6.91%
11,594 $1.19 Million
Q2 2023

Jul 18, 2023

SELL
$108.61 - $118.38 $151,945 - $165,613
-1,399 Reduced 11.43%
10,845 $1.25 Million
Q1 2023

Apr 17, 2023

BUY
$102.94 - $114.86 $229,144 - $255,678
2,226 Added 22.22%
12,244 $1.3 Million
Q4 2022

Jan 24, 2023

SELL
$87.44 - $112.11 $2,098 - $2,690
-24 Reduced 0.24%
10,018 $0
Q3 2022

Oct 13, 2022

SELL
$84.53 - $94.96 $16,990 - $19,086
-201 Reduced 1.96%
10,042 $864,000
Q2 2022

Jul 26, 2022

SELL
$83.49 - $94.64 $172,156 - $195,147
-2,062 Reduced 16.76%
10,243 $934,000
Q1 2022

Apr 27, 2022

BUY
$73.51 - $82.4 $54,838 - $61,470
746 Added 6.45%
12,305 $1.01 Million
Q4 2021

Mar 04, 2022

BUY
$72.28 - $90.54 $835,484 - $1.05 Million
11,559 New
11,559 $886,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $266B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bill Few Associates, Inc. Portfolio

Follow Bill Few Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill Few Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bill Few Associates, Inc. with notifications on news.